Guangdong Zhongsheng Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Guangdong Zhongsheng Pharmaceutical Co Ltd cash flow-to-debt ratio. Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2025, meaning its operating cash flow of CN¥88.00 Million could theoretically repay 0% of its total liabilities (CN¥1.04 Billion) in one year. Check Guangdong Zhongsheng Pharmaceutical Co L (002317) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Cash flow-to-debt ratio of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024. Historical debt coverage capacity for Guangdong Zhongsheng Pharmaceutical Co Ltd across 19 annual periods. Check Guangdong Zhongsheng Pharmaceutical Co L investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Guangdong Zhongsheng Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2006–2024)
Guangdong Zhongsheng Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2006 to 2024. Year-by-year debt coverage analysis for Guangdong Zhongsheng Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Guangdong Zhongsheng Pharmaceutical Co L cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.22x | CN¥337.84 Million | CN¥1.54 Billion | ▲ +122.0% |
| 2023 | 0.10x | CN¥190.61 Million | CN¥1.93 Billion | ▲ +206.3% |
| 2022 | 0.03x | CN¥63.07 Million | CN¥1.96 Billion | ▼ -92.9% |
| 2021 | 0.46x | CN¥622.77 Million | CN¥1.36 Billion | ▲ +277.8% |
| 2020 | 0.12x | CN¥138.93 Million | CN¥1.15 Billion | ▼ -34.0% |
| 2019 | 0.18x | CN¥251.16 Million | CN¥1.37 Billion | ▼ -27.5% |
| 2018 | 0.25x | CN¥326.78 Million | CN¥1.29 Billion | ▼ -23.1% |
| 2017 | 0.33x | CN¥369.91 Million | CN¥1.13 Billion | ▼ -22.2% |
| 2016 | 0.42x | CN¥338.28 Million | CN¥801.23 Million | ▲ +168.9% |
| 2015 | 0.16x | CN¥192.25 Million | CN¥1.22 Billion | ▼ -36.4% |
| 2014 | 0.25x | CN¥100.60 Million | CN¥407.63 Million | ▼ -47.1% |
| 2013 | 0.47x | CN¥110.95 Million | CN¥238.04 Million | ▼ -50.8% |
| 2012 | 0.95x | CN¥142.38 Million | CN¥150.41 Million | ▲ +24.1% |
| 2011 | 0.76x | CN¥70.56 Million | CN¥92.54 Million | ▼ -20.6% |
| 2010 | 0.96x | CN¥91.72 Million | CN¥95.53 Million | ▲ +3.2% |
| 2009 | 0.93x | CN¥100.89 Million | CN¥108.46 Million | ▲ +82.0% |
| 2008 | 0.51x | CN¥72.86 Million | CN¥142.53 Million | ▲ +73.1% |
| 2007 | 0.30x | CN¥49.35 Million | CN¥167.17 Million | ▲ +152.1% |
| 2006 | 0.12x | CN¥17.91 Million | CN¥152.93 Million | — |